￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of whether the disease will relapse rapidly after discontinuation of Pitobrutinib/Pitobrutinib (Zepali)

2026-02-01 22:25:32

Check Details
Is the dosage form of Talazoparib (Tazena) capsules or other forms?

2026-02-01 22:25:32

Check Details
Crizotinib price and reference after medical insurance reimbursement in 2026

2026-02-01 22:25:32

Check Details
Mechanism and pharmacological analysis of aprocitentan in the treatment of pulmonary arterial hypertension

2026-02-01 22:25:32

Check Details
Clinical application effect of tilpotide/tilsiparatide (Mufenda) in the treatment of diabetes

2026-02-01 22:25:32

Check Details
Comprehensive explanation of the mechanism of action and clinical efficacy of Pitobrutinib/Pitobrutinib (Zepali)

2026-02-01 22:25:32

Check Details
Safety analysis of combined use of talazoparib (Tazena) and enzalutamide

2026-02-01 22:25:32

Check Details
Analysis of whether crizotinib (Xalkori) is the last line of treatment for patients

2026-02-01 22:25:32

Check Details
Detailed analysis and explanation of pharmacological effects, indications and clinical application value of Omarigliptin tablets

2026-02-01 22:25:32

Check Details
Where can I buy lecanemab-LEQEMBI in the country?

2026-02-01 22:25:32

Check Details
What is golodirsen and analysis of its pharmacological effects

2026-02-01 22:25:32

Check Details
Disitamab drug purchase reference and cost explanation

2026-02-01 22:25:32

Check Details
Category
相关知识